Chemotherapy appears to be independently associated with reduced pain severity in advanced pancreatic cancer, reinforcing the ...

The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist ...

A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently ...

Although neurological symptoms (motor deficits, sensory impairment) were more frequent in patients with sitting-related ...

Adults who received cryoanalgesia during minimally invasive thoracic surgery experienced higher neuropathic pain scores at ...

In this cross-sectional study, one-third of federally qualified health centers (FQHCs) in the United States did not provide onsite prenatal care and instead referred pregnant patients to external ...

In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ...

A June 2026 NPR investigation found the commercial gut microbiome market has run far ahead of what the science actually ...

In this pooled analysis of randomized crossover trials, chronic mild sleep restriction was associated with modest increases ...

In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase ...

Immediate septoplasty is more costly but more clinically effective than medical management for deviated septum. 2. Over a ...

Administration of perioperative intravenous vitamin C for percutaneous renal biopsy may not reduce the rate of bleeding ...